55 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
GRFS Grifols, S.A. $21.19 $14.49B Downtrend
Article Searches
GRFS: Barclays starts at Overweight http://www.briefing.com/investor/popuppages/articlepopup.aspx?articleId=UD20180601083059 Jun 01, 2018 - Barclays issues rating change for GRFS
Grifols S.A. goes ex-dividend tomorrow https://seekingalpha.com/news/3360791-grifols-s-goes-ex-dividend-tomorrow?source=feed_news_all May 31, 2018 - Grifols S.A. (NASDAQ:GRFS) had declared $0.250975/share semi-annual dividend.Payable June 5; for shareholders of record May 31; ex-div June 1.
'Safer' Dividend Healthcare Top WallStar Gainers Are Gilead, Sanofi, Amerisource, Anthem, And Johnson, Per Broker May Targets https://seekingalpha.com/article/4177005-safer-dividend-healthcare-top-wallstar-gainers-gilead-sanofi-amerisource-anthem-johnson-per?source=feed_all_articles May 24, 2018 - Gilead took net gain safer May dividend Healthcare WallStar honors. Its 27.4% net gain was 23% better than Sanofi's, and 32% ahead of AmerisourceBergen's result per analyst targets of 5/22/18.22 of 31
3Pea Is A Payment Processor With >40% Organic Growth Selling For Half Of Peer Multiples https://seekingalpha.com/article/4176361-3pea-payment-processor-40-percent-organic-growth-selling-half-peer-multiples?source=feed_tag_editors_picks May 22, 2018 - Payments processor serving the niche plasma donation market. Share winner in a growing industry with revenue potentially 4-8x higher in four years.Strong financial profile with high margins, ROIC, and
Engadine Partners LLP Buys Grifols SA, Monster Beverage Corp, Sells GCP Applied Technologies ... http://www.gurufocus.com/news/679429/engadine-partners-llp-buys-grifols-sa-monster-beverage-corp-sells-gcp-applied-technologies-inc-cocacola-european-partners-plc May 09, 2018 - Engadine Partners LLP Buys Grifols SA, Monster Beverage Corp, Sells GCP Applied Technologies Inc, Coca-Cola European Partners PLC, Stocks: GRFS,MNST,GCP,CCE,, release date:May 09, 2018
Now Could Be The Right Time To Buy Grifols With Worries Over Trade With China https://seekingalpha.com/article/4162177-now-right-time-buy-grifols-worries-trade-china?source=feed_sector_healthcare Apr 10, 2018 - Sales and earnings growth have been tremendous.Profit margins were over 15% last year.The annual report was just released.The stock may be down on worries with China trade.
3 Things In Biotech, March 11: Aradigm Retries, Pfizer Glides, VBL Crashes https://seekingalpha.com/article/4155401-3-things-biotech-march-11-aradigm-retries-pfizer-glides-vbl-crashes?source=feed_sector_healthcare Mar 12, 2018 - Aradigm and Grifols try for European approval.Pfizer's GI advisory committee goes rather smoothly.VBL Therapeutics fails on glioblastoma treatment.
ADMA Biologics: Almost Ready To Run Between The Toes Of Giants https://seekingalpha.com/article/4153615-adma-biologics-almost-ready-run-toes-giants?source=feed_sector_healthcare Mar 06, 2018 - ADMA’s lead product candidate has generated very positive clinical data, and is positioned to meet a very high unmet medical need.ADMA has acquired a specialised hyper-immune fractionation facility, w
Henry Schien to Distribute Grifols Product in United States http://www.zacks.com/stock/news/294616/henry-schien-to-distribute-grifols-product-in-united-states?cid=CS-ZC-FT-294616 Mar 06, 2018 - We expect Henry Schien's (HSIC) partnership with Grifols to be strategically accretive to its portfolio given the rising demand for saline products in U.S. market.
Aradigm: Points Of Discussion https://seekingalpha.com/article/4142661-aradigm-points-discussion?source=feed_sector_healthcare Feb 02, 2018 - The CRL was a setback.Some considerations for investors are posed here.EMA?

Pages: 123456

Page 1>

Related Companies

Name Exchange Price Mkt Cap
BMRN BioMarin Pharmaceutical Inc. NASDAQ $100.11 $17.69B
JAZZ Jazz Pharmaceuticals plc NASDAQ $179.88 $10.84B
PRGO Perrigo Company NYSE $77.72 $10.76B
ALNY Alnylam Pharmaceuticals, Inc. NASDAQ $105.88 $10.64B
MYL Mylan N.V. NASDAQ $36.15 $18.63B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for Grifols, S.A.
GRFS - Google Finance https://www.google.com/finance?q=GRFS Industry related info and international coverage Summary News
GRFS - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=GRFS Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options